Glen Eagle Advisors, LLC Johnson & Johnson Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 111,006 shares of JNJ stock, worth $17.8 Million. This represents 2.97% of its overall portfolio holdings.

Number of Shares

111,006

Previous 17,913 519.7%

Holding current value

$17.8 Million

Previous $2.3 Billion 606.77%

% of portfolio

2.97%

Previous 1.89%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $13.4 Million - $14.7 Million	93,093 Added 519.7%	111,006 $16.2 Billion
Q1 2024 Jul 03, 2024	BUY	$155.22 - $162.74 $18.1 Million - $19 Million	116,558 New	116,558 $18.4 Billion
Q4 2023 Aug 13, 2024	SELL	$145.6 - $158.88 $74,547 - $81,346	-512 Reduced 0.43%	119,212 $18.7 Billion
Q3 2023 Aug 13, 2024	BUY	$155.75 - $174.48 $193,441 - $216,704	1,242 Added 1.05%	119,724 $18.6 Billion
Q2 2023 Aug 13, 2024	BUY	$154.35 - $166.11 $314,410 - $338,366	2,037 Added 1.75%	118,482 $19.6 Billion
Q1 2023 Aug 13, 2024	BUY	$151.05 - $180.26 $520,669 - $621,356	3,447 Added 3.05%	116,445 $18 Billion
Q4 2022 Aug 13, 2024	BUY	$160.2 - $179.79 $146,422 - $164,328	914 Added 0.82%	112,998 $20 Billion
Q3 2022 Aug 13, 2024	SELL	$161.33 - $179.52 $817,781 - $909,986	-5,069 Reduced 4.33%	112,084 $18.3 Billion
Q2 2022 Aug 13, 2024	BUY	$168.19 - $186.01 $880,811 - $974,134	5,237 Added 4.68%	117,153 $20.8 Billion
Q1 2022 Aug 13, 2024	SELL	$158.14 - $179.59 $86,660 - $98,415	-548 Reduced 0.49%	111,916 $19.8 Billion
Q4 2021 Aug 13, 2024	BUY	$155.93 - $173.01 $188,831 - $209,515	1,211 Added 1.09%	112,464 $19.2 Billion
Q3 2021 Aug 13, 2024	BUY	$161.5 - $179.47 $1.43 Million - $1.59 Million	8,871 Added 8.66%	111,253 $18 Billion
Q2 2021 Aug 13, 2024	BUY	$159.48 - $171.07 $156,609 - $167,990	982 Added 0.97%	102,382 $16.9 Billion
Q1 2021 Aug 13, 2024	BUY	$153.07 - $170.48 $223,635 - $249,071	1,461 Added 1.46%	101,400 $16.7 Billion
Q4 2020 Aug 13, 2024	SELL	$137.11 - $157.38 $2.28 Million - $2.62 Million	-16,619 Reduced 14.26%	99,939 $15.7 Billion
Q3 2020 Aug 13, 2024	BUY	$140.38 - $153.83 $340,842 - $373,499	2,428 Added 2.53%	98,393 $14.6 Billion
Q2 2020 Aug 13, 2024	BUY	$128.81 - $155.51 $10.5 Million - $12.7 Million	81,737 Added 574.48%	95,965 $13.5 Billion
Q1 2020 Aug 13, 2024	BUY	$111.14 - $153.99 $8,224 - $11,395	74 Added 0.52%	14,228 $1.87 Billion
Q4 2019 Aug 13, 2024	SELL	$127.5 - $146.44 $198,772 - $228,299	-1,559 Reduced 9.92%	14,154 $2.06 Billion
Q3 2019 Aug 13, 2024	SELL	$126.95 - $142.14 $135,582 - $151,805	-1,068 Reduced 6.36%	15,713 $2.03 Billion
Q2 2019 Aug 13, 2024	SELL	$131.15 - $144.24 $10,098 - $11,106	-77 Reduced 0.46%	16,781 $2.32 Billion
Q1 2019 Aug 13, 2024	SELL	$125.72 - $139.79 $12.5 Million - $13.9 Million	-99,700 Reduced 85.54%	16,858 $2.36 Billion
Q4 2018 Aug 13, 2024	SELL	$122.84 - $147.84 $4,176 - $5,026	-34 Reduced 0.2%	16,767 $2.16 Billion
Q3 2018 Aug 13, 2024	SELL	$121.58 - $142.88 $123,160 - $144,737	-1,013 Reduced 5.69%	16,801 $2.32 Billion
Q2 2018 Aug 13, 2024	SELL	$119.4 - $131.76 $123 Million - $136 Million	-1,031,213 Reduced 98.3%	17,814 $2.16 Billion
Q1 2018 Aug 14, 2024	SELL	$125.1 - $148.14 $12.3 Million - $14.6 Million	-98,645 Reduced 84.63%	17,913 $2.3 Billion
Q1 2018 Aug 13, 2024	BUY	$125.1 - $148.14 $129 Million - $153 Million	1,030,981 Added 5713.07%	1,049,027 $2.3 Billion
Q4 2017 Aug 13, 2024	BUY	$131.22 - $143.62 $192,893 - $211,121	1,470 Added 8.87%	18,046 $2.52 Billion
Q3 2017 Aug 13, 2024	SELL	$129.47 - $135.38 $12.9 Million - $13.5 Million	-99,982 Reduced 85.78%	16,576 $2.16 Billion
Q2 2017 Aug 12, 2024	BUY	N/A	1,264 Added 6.67%	20,205 $2.67 Billion
Q1 2017 Aug 12, 2024	BUY	N/A	419 Added 2.26%	18,941 $2.36 Billion
Q4 2016 Aug 12, 2024	SELL	N/A	-98,036	18,522 $2.13 Billion

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Johnson & Johnson Transaction History